348 A GENOME WIDE ASSOCIATION STUDY ON JOINT SPACE WIDTH IDENTIFIES A NEW GENE INVOLVED IN CARTILAGE THICKNESS AND OSTEOARTHRITIS  by Betancourt, M.C. Castaño et al.
Poster Presentations / Osteoarthritis and Cartilage 19S1 (2011) S53–S236 S157
346
VITAMIN D AND FALLS AND FRACTURES IN OLDER WOMEN
Y. Fernandez1, R. Batra1, D. Prieto-Alhambra2, T. Spector3, K. Javaid1,
N. Arden1,4. 1NIHR Musculoskeletal BRU. Univ. of Oxford, Oxford, United
Kingdom; 2Univ.t Autonoma de Barcelona, Departament de Med., Barcelona,
Spain; 3Dept. of Twin Res. and Genetic Epidemiology, King’s Coll. London.,
London, United Kingdom; 4MRC Environmental Epidemiology Unit,
Southampton Gen. Hosp., Southampton, United Kingdom
Purpose: The effect of vitamin D status on falls is not consistent. We
aimed to assess the existing relationship between vitamin D, measured
by 25-hydroxyvitamin D plasma concentrations and the occurrence of
falls and fractures.
Methods: Design, participants and setting: Prospective population-based
longitudinal study involving 775 women aged 43–67 from a general
practice in Chingford, North-East London followed prospectively for
12 years.
Measurements: Falls and fractures were assessed by standardized,
nurse-administered questionnaires. 25-hydroxy-vitamin D serum
concentrations (25-OH-D) were determined by Radioimmunoassay (RIA)
and analysed as a continuous variable. Vitamin D levels were treated
as a categorical variable with 3 levels (Deﬁcient (<20ng/ml), Insufﬁcient
(20–29ng/ml) and Sufﬁcient (≥30ng/ml)).
Statistics: The associations between 25-OH-D and falls and fractures were
assessed using multivariate Cox-proportional hazards regression models.
These were adjusted for age, BMI, age at menopause, HRT status and
vitamin D and Calcium supplements. In order to test for interactions
between 25-OH-D and season; multiplicative terms were introduced in
the model.
Results: 775 women (mean age 57.15 years) had 25-OH-D levels available
and were included in the study. 215 (27.7%) had deﬁcient vitamin D levels
(<20ng/mL), 330(42.6%) were insufﬁcient (20–29ng/mL) and 230 (29.7%)
had sufﬁcient vitamin D levels (≥30ng/mL).
An increase of 10ng/ml of 25-OH-D led to an 11% (95%CI 0.80, 0.99)
decreased risk of falls (p = 0.025). After adjusting for other explanatory
variables (age, BMI, HRT use and age at menopause), this remained
signiﬁcant. After adjusting further for supplement use, the effect of
vitamin D did not change (p =0.041) and interaction terms between
25-OH-D and season were not signiﬁcant (p = 0.65).
In contrast, the results of Cox regression showed no association between
25-OH-D and risk of fractures. After adjusting for other explanatory
variables (age, BMI, age at menopause, HRT status and supplements),
these results did not change.
Conclusions: In this observational population-based study, low serum
vitamin D levels are associated with an increased risk of falls in post-
menopausal Caucasian women. No association with incident fractures
could be demonstrated.
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GENE EXPRESSION PROFILING OF CARTILAGE DEGRADATION IN
A MOUSE MODEL OF OSTEOARTHRITIS IDENTIFIES SIGNIFICANT
ALTERATION IN KEY MOLECULAR PROCESSES
M.D. Gardiner, A. Chanalaris, H. Nagase. Imperial Coll. London, London,
United Kingdom
Purpose: Proﬁling the changes in chondrocyte gene expression during
the initiation and progression of osteoarthritis (OA) identiﬁes key early
events in the disease pathogenesis. Studying OA progression using human
cartilage is challenging owing to the difﬁculty in acquiring tissue. The
surgically induced destabilisation of the medial meniscus (DMM) mouse
model provides genetically homogenous cartilage at any disease stage.
Comparison of diseased and control cartilage provides an insight into
the molecular changes occurring in early OA.
Methods: The DMM mouse model of OA was used to study chondrocyte
whole genome expression changes in mouse knee articular cartilage at
2, 4 and 8 weeks following surgery. Histological sections were used
to assess the cartilage degradation. A new microdissection technique
enabled targeted collection of pure mouse articular cartilage from
the medial tibial plateau. RNA isolated from OA and control joint
cartilage was pooled and ampliﬁed using NuGEN Ovation Pico before
hybridization to Illumina Mouse WG-6 v2.0 Expression BeadChips. Two-
way ANOVA was performed to investigate the interaction of time and
disease. Functional annotation clustering (FAC) and pathway analysis
were performed using DAVID. A selection of genes was validated using
real-time RT-PCR.
Results: In OA cartilage at 2 weeks there was signiﬁcantly increased
expression of metallopeptidases, including Mmp2, Mmp3, Mmp13,
Mmp14, Adamts4 and Adamts12; only Mmp2 and Mmp3 remained
increased at 4 and 8 weeks. Adamts5 expression was not detected.
In addition, many serpin serine protease inhibitors were signiﬁcantly
decreased, which is likely to further promote matrix catabolism. There
was a strong anabolic response at 2 weeks with increased expression
of many minor collagens and small leucine-rich repeat proteoglycans
(SLRPs). Fibromodulin was strongly increased in OA cartilage at all time
points. Cytoskeletal organisation genes were signiﬁcantly decreased in
expression at 2 and 4 weeks but not 8 weeks. In addition, genes
involved in promoting apoptosis, were signiﬁcantly decreased. Genes not
previously identiﬁed as expressed by chondrocytes included tenascin-W,
which was signiﬁcantly increased in OA cartilage at all time points.
Myeloperoxidase was unaltered at 2 weeks but strongly increased at
4 weeks in OA cartilage.
Conclusions: Application of a new microdissection technique enabled
gene expression analysis of pure mouse articular cartilage during OA
progression. This technique can be used to isolate other joint tissues.
In OA cartilage we identiﬁed an early increase in metalloproteinase
gene expression without increase in tissue inhibitors and signiﬁcant
dysregulation of cytoskeletal genes. Gene expression changes also
appeared to promote cell survival. The strong increase in tenascin-W
warrants further investigation.
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A GENOME WIDE ASSOCIATION STUDY ON JOINT SPACE WIDTH
IDENTIFIES A NEW GENE INVOLVED IN CARTILAGE THICKNESS AND
OSTEOARTHRITIS
M.C. Castano Betancourt1,2, A. Valdes3, F. Cornelis4, H. Kerkhof1,2,
S. Doherty5, M. Wheeler5, W. Zhang5, R. Maciewicz6, K. Muir7,
D. Hart3, S. Metrustry3, M. Mangino3, N. Arden8, F. Cailotto4,
M. Peters1,2, F. Rivadeneira1,2, A. Hofman1, A.G. Uitterlinden1,2,
M. Doherty5, T. Spector3, R. Lories4, J.B. van Meurs1,2. 1Dept. of Internal
Med., ErasmusMC, Rotterdam, Netherlands; 2Netherlands Genomics
Initiative-Sponsored by the Netherlands Consortium for Hlth.y Aging,
Rotterdam, Leiden, Netherlands; 3Dept of Twin Res. and Gen Epidemiology,
St. Thomas’ Hosp., King’s Coll. London, London, United Kingdom; 4Lab. for
Skeletal Dev. and Joint Disorders, KU Leuven, Leuven, Belgium; 5Univ. of
Nottingham, Nottingham, United Kingdom; 6Astra Zeneca, London, United
Kingdom; 7Univ. of Warwick, Coventry, United Kingdom; 8Univ. of Oxford,
Oxford, United Kingdom
Purpose: To identify new genes involved in osteoarthritis (OA) by
performing a genome wide association study (GWAS) on cartilage
thickness.
Methods: We performed a GWAS on radiographically measured minimal
joint space width (mJSW) of the hip in 6523 participants from the
Rotterdam Study I and II. The top signal was replicated in a total of 4443
individuals from 3 studies in the UK: Chingford, GOAL and TwinsUK.
We assessed the risk for hip OA in 3212 cases and 9869 controls
combining data from 6 study populations. Immunohistochemical staining
was performed on the identiﬁed gene during mouse limb development,
and in mature healthy and OA mouse joints
Results: The GWAS on mJSW identiﬁed a SNP on chromosome 19 to
be associated with larger joint space width (P =4.8×10−10, beta 0.09,
95% CI 0.06–0.12). The association was replicated in the 3 UK-cohorts
for an overall meta-analysis P value of 1.1×10−11 (beta: 0.09, 95% CI
0.06–0.11). The minor allele for larger joint space was also associated
with decreased risk for hip OA (OR 0.88, 95%CI 0.82–0.93, p = 7×10−5).
The SNP was consistently associated with mJSW in individuals without
hipOA, suggesting that the effect is on cartilage thickness rather then
degradation.
The SNP is located in a gene that has recently been linked to
wnt-signalling, and our results now suggest a role in chondrogenic
differentiation. We observed nuclear staining of mature chondrocytes
and the developing muscle in the developmental limb bud, but much
lower expression in the joint interzone. Postnatal joints show clear
expression in the growth plate and cartilage. When mouse knee joints
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were challenged by in vivo collagenase treatment, increased staining of
the chondrocytes was seen.
Conclusions: We identiﬁed a genetic variant on chromosome 19 to be
associated with cartilage thickness and hip OA. The variant is located
in a gene showing an expression pattern that supports a role in
chondrogenetic differentiation. GWAS for underlying endophenotypes
might be a proliﬁc route to identify risk loci for complex diseases
such as OA.
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GLOBAL DNA METHYLATION ANALYSIS IN OSTEOARTHRITIS SYNOVIAL
FIBROBLASTS
J-Y. Choe1,2, S-H. Park1,2, S-K. Kim1,2, H-Y. Jung1,2, H-J. Lee1,2, J. Kim1,2.
1Catholic Univ. of Daegu, Sch. of medicine, Daegu, Korea, Republic of ;
2Arthritis and Autoimmunity Res. Ctr., Daegu, Korea, Republic of
Purpose: Aberrant transcription proﬁling in osteoarthritis(OA) synovial
ﬁbroblasts(SFs) lacking consistent speciﬁc genetic mutations suggests
that epigenetic mechanisms along with the environmental factors
may be involved in its pathogenesis. Compared to those from
normal or rheumatoid arthritis(RA) SFs, over-activated OASFs have an
important role in the destruction of normal joint architecture, and
the imprinted, phenotypical aggressiveness could be determined by
epigenetic mechanism. To investigate a global DNAmethylation of human
OASFs using methylated DNA isolation assay (MeDIA)-CpG promoter
microarray, and compared it with SFs of RA patients or healthy controls
in Korean population.
Methods: Human synovial tissue samples obtained during undergoing
total knee joint replacement surgery in 2 OA and 3 RA patients. 2
Normal synovium was collected by arthroscopic or open knee surgery
of traumatic ligament injury of healthy populations. Total DNA extracted
from SFs using the QIAamp DNA mini and blood kit protocol (Qiagen,
Hilden, Germany). To discover novel hypo- or hypermethylated genes
in OA by genome-wide search, we introduce a MeDIA-coupled CpG
microarray method for directly identifying differentially methylated
regions of the genomes in each pooled synovial cells between OA and RA
patients. The methylation status of promising candidates was validated
by quantitative pyrosequencing assay in each synovial cells.
Results: In two CpG microarray, 4 genes were screened as 5
fold hypomethylated targets among 1,714 porbes. Through stepwise
subtraction processes, we ﬁnally selected four candidate targets. Among
of these targets, two genes, APEX1 gene(gt-OA1) and TGFB1 gene(gt-OA2)
have shown so far a signiﬁcant decrease in the methylation frequency
in OA when compared in independent groups of synovial DNA samples
from OA patients with from RA and normal controls.
Conclusions: APEX1 and TGFB1 gene promoter is hypomethylated in
OASFs than OA and healthy controls. Pathophysiologic correlation and
their role as a diagnostic or prognostic marker should be investigated in
a larger number of patients group hereafter.
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HFE C282Y HOMOZYGOSITY IS ASSOCIATED WITH AN INCREASED
RISK OF TOTAL HIP REPLACEMENT FOR OSTEOARTHRITIS IN MEN
BUT NOT WOMEN
Y. Wang1, L. Gurrin2, A. Wluka1, N. Bertalli2, N. Osborne2, M. Delatycki3,
G. Giles4, D. English4, J. Hopper2, J. Simpson2, S. Graves2, K. Allen3,
F. Cicuttini1. 1Monash Univ., Melbourne, Australia; 2Univ. of Melbourne,
Melbourne, Australia; 3Murdoch Childrens Res. Inst., Melbourne, Australia;
4The Cancer Council of Victoria, Melbourne, Australia
Purpose: The evidence for an association between mutations in HFE
gene related to hemochromatosis and risk of hip or knee osteoarthritis is
inconsistent. Total joint replacement is considered a surrogate measure
for symptomatic end-stage osteoarthritis. This study aimed to examine
the relationship between HFE gene mutations and risk of total hip and
knee replacement in a population-based cohort.
Methods: The Melbourne Collaborative Cohort Study is a prospective
cohort study that commenced recruitment in 1990. Participants born in
Australia, New Zealand, the United Kingdom, or Ireland (n =27,848) were
genotyped for the HFE C282Y variant. Total hip and knee replacements for
osteoarthritis during 2001–2009 were ascertained from the Australian
Orthopaedic Association National Joint Replacement Registry. Hazard
ratios (HRs) and conﬁdence intervals (CIs) were obtained from Cox
regression.
Results: Compared to those with no C282Y variant, C282Y homozygotes
were at increased risk of total hip replacement (HR 1.94, 95% CI 1.04–
3.62). The association was stronger for men (HR 3.34, 95% CI 1.48–7.52)
than for women (HR 1.22, 95% CI 0.46–3.27) (p for interaction = 0.21).
Only 3 C282Y homozygotes had total knee replacements; the HR was
0.51 (95% CI 0.16–1.57). C282Y/H63D compound heterozygosity was not
related to the risk of total hip or knee replacement.
Conclusions: HFE C282Y homozygosity was associated with increased
risk of total hip replacement for osteoarthritis for men but not for
women. The mechanism for this is unknown and the ﬁndings need to
be conﬁrmed in future studies.
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THE mtDNA HAPLOGROUPS INFLUENCE THE PROGRESSION OF
OSTEOARTHRITIS (OA)
I. Rego-Pe´rez1, M. Ferna´ndez-Moreno1, A´. Soto-Hermida1, S. Pe´rtega2,
N. Oreiro1, C. Ferna´ndez-Lo´pez1, F.J. Blanco1. 1INIBIC-CHUAC.
Rheumatology Div., A Corun˜a, Spain; 2Epidemiology Unit. INIBIC-CHUAC,
A Corun˜a, Spain
Purpose: To analyze the inﬂuence of the mtDNA haplogroups in the
progression of the osteoarthritis (OA) disease.
Methods: The DNA of 282 knee and/or hip OA samples from Hospital
Universitario A Corun˜a was isolated to obtain their mtDNA haplogroups.
Knee and/or hip radiographs from all these samples were obtained at
two stages of the OA disease of at least 36 months between them,
and evaluated according to the K/L scale from grade 0 to IV. Statistical
analyses included Kaplan-Meier survival curves for each haplogroup or
cluster tested, as well as Cox regression models taking into account
another variables such as gender, haplogroup (or cluster) and body mass
index (BMI).
Results: For this study, two types of progression were established: OA
progression and severity progression. We considered OA progression
when a patient evolved from K/L grade 0-I to K/L grade II-III or K/L
grade IV, and from K/L grade II-III to K/L grade IV, in at least one of the
joints analyzed. The results obtained showed that the OA progression
varies signiﬁcantly according to the mtDNA haplogroups (p = 0.030),
and the main differences were detected when compared patients that
belonged to the cluster TJ (better progressors) with patients of the
cluster KU (worse progressors) (p = 0.083) (Figure 1). On the other hand,
we considered severity progression when a patient evolved to knee
or hip prosthesis from an initial K/L grade III or less. In this case, the
results obtained showed that patients carrying the most common mtDNA
haplogroup H had a worse severity progression than non-H patients
(p = 0.035) (Figure 2). The Cox regression model also showed that males
evolved worse than females (p = 0.028).
Conclusions: The mtDNA haplogroups inﬂuence the progression of OA;
these results strength the role of the mitochondria in the OA disease.
Fig. 1. Kaplan–Meier survival curve showing the different OA progression
between clusters KU and TJ.
